Startups
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
Overview
Location
Switzerland, Geneva
Employees
11-50
Total raised
$6.27M
Founded date
2016
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 26, 2020 | Funding round | $2.07M |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 15, 2023 | GliaPharm secures $4.2 million to advance its lead program | |
| Oct 28, 2022 | GliaPharm and UCB enter drug discovery research collaboration | |
| Jul 4, 2022 | Transmutex, V-Labs, GliaPharm and Deasyl get FIF Funding | The FIF is the instrument for fostering innovation and the scale up of promising companies from the Canton of Geneva at the service of the United Nations (UN) Sustainable Development Goals (SDGs). The FIF is supported by the State of Geneva... |
| Feb 28, 2022 | GliaPharm braces to enter the clinical phase | |
| May 26, 2020 | Geneva-based GliaPharm completes a CHF 2 million financing round | GliaPharm specialises in the research and development of novel therapies to treat and prevent neurological diseases by targeting glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions... |
| May 26, 2020 | Geneva-based GliaPharm completes a CHF 2 million financing round | |
| Jan 14, 2019 | Six Swiss startups among the finalists of Hello tomorrow challenge | The Hello Tomorrow global summit brings together like-minded players from different fields of technology to discover how deep technologies can solve the world's toughest challenges. One of the highlights of the summit is the startup challen... |
| Aug 6, 2018 | FIT grants CHF 400'000 to four new Western Switzerland startups | |
| Sep 7, 2017 | Genohm’s client base continues to grow |
Reviews 0
FAQ about GliaPharm SA
When was GliaPharm SA founded?
GliaPharm SA was founded in 2016.
How much funding has GliaPharm SA raised?
GliaPharm SA has raised $6.27M in total across 2 funding rounds.
What funding rounds has GliaPharm SA raised?
Parsers VC lists 2 funding rounds of GliaPharm SA, among them a funding round of $2.07M on May 26, 2020.
What has the press written about GliaPharm SA?
Parsers VC has collected 10 articles mentioning GliaPharm SA, among them “GliaPharm secures $4.2 million to advance its lead program” (Dec 15, 2023) and “GliaPharm and UCB enter drug discovery research collaboration” (Oct 28, 2022).
Is GliaPharm SA still active?
Yes, GliaPharm SA is active; its latest activity on Parsers VC dates from Sep 17, 2024.